Try our Advanced Search for more refined results
Health
- 
									October 14, 2025
									NC Court Denies Early Ruling In Hospital Antitrust CaseOwners of a healthcare system in western North Carolina couldn't prevail in an early summary judgment attempt to avoid antitrust claims, after a North Carolina Business Court judge said the complexity of the request at hand precludes a "piecemeal" ruling. 
- 
									October 14, 2025
									Full 3rd Circ. Won't Rethink $45M CareDx False Ad CaseThe Third Circuit on Tuesday turned down medical testing company CareDx's request to have a full panel mull whether to reinstate a $45 million jury award in a false advertisement case over genetic testing technology against rival Natera. 
- 
									October 14, 2025
									Relief Concerns Grow As Sectoral Tariff Actions BuildImporters' hopes for relief from industrywide tariffs are lagging alongside the trade deals President Donald Trump is trying to broker for some goods, while the administration's accelerated rollout of sectoral levies is also stoking concerns the government may be hamstringing its onshoring goals. 
- 
									October 14, 2025
									Embryo Loss Class Claims Hinge On Calif. Suit, Judge SaysA Connecticut federal judge may pause a proposed class action blaming CooperSurgical Inc. for embryo losses during in vitro fertilization until a class certification motion is decided in a first-filed case in California, but the plaintiff will have until the end of the month to decide if she wants to proceed with only her direct claims instead. 
- 
									October 14, 2025
									6th Circ. Won't Revive Allergy Tester's Antitrust CaseThe Sixth Circuit refused to revive an allergy testing and treatment company's antitrust case accusing an insurer and a medical group of conspiring to squeeze it out of the market, after finding that doctors are the ones being directly harmed by the alleged activity. 
- 
									October 14, 2025
									Texans Say Drinking Water Tainted With PFAS From Military BaseResidents and local businesses in Lubbock, Texas, are suing 3M, DuPont de Nemours Inc. and others over alleged exposure to so-called forever chemicals that leached into their well water from firefighting foam used on a nearby former U.S. Air Force base and caused a woman's death. 
- 
									October 14, 2025
									Meet HHS General Counsel Michael StuartMichael Stuart, a former chief federal prosecutor for West Virginia, has been confirmed by the U.S. Senate to serve as general counsel for the Department of Health and Human Services, where he has promised to make healthcare fraud enforcement a priority. 
- 
									October 14, 2025
									Humana's 2025 Medicare Ratings Sound, Judge SaysA Texas federal judge on Tuesday upheld the Centers for Medicare & Medicaid Services' 2025 star ratings for some of Humana Inc.'s Medicare Advantage plans, saying the agency had the right to hand down a poor rating to the insurer. 
- 
									October 14, 2025
									Aetna Dodges Colo. County's $1.1M Suit Over Unpaid RebatesA Colorado federal judge has dismissed a county's lawsuit alleging Aetna Life Insurance Co. withheld more than $1 million in pharmacy rebates under an unenforceable early termination clause, agreeing with the insurance company that the clause is valid and enforceable. 
- 
									October 14, 2025
									Freshfields Guides J&J's Planned Orthopedics Unit SpinoffJohnson & Johnson said Tuesday it intends to separate its orthopedics business into a stand-alone company within the next 18 to 24 months, with Freshfields LLP advising on the planned spinoff of the unit. 
- 
									October 14, 2025
									Colo. Biz Accuses VA Of Ignoring Veteran-Owned SuppliersA Colorado company accused the U.S. Department of Veterans Affairs of improperly greenlighting purchases of electrocardiogram leads from a large overseas business when American-made items are available from it and other veteran-owned small businesses. 
- 
									October 14, 2025
									Ōura Valuation Soars To $11B After $900M Financing RoundFitness-tracking ring maker Ōura on Tuesday revealed it had reached a roughly $11 billion valuation after securing over $900 million in a funding round, which it says will help it develop new technologies, speed up artificial intelligence and product innovation, and expand global distribution. 
- 
									October 14, 2025
									Justices Seek SG Input In 'Lightning Rod' Health Ministry CaseThe U.S. Supreme Court Tuesday asked for the U.S. solicitor general to weigh in on a "lightning rod" of a case involving the regulation of nonprofit healthcare-sharing ministries that provide cheap, Christian-friendly health insurance options but aren't legally bound to pay for medical care. 
- 
									October 14, 2025
									Judges Back Ga. County's Use Of Outside Attys In Opioid SuitThe Georgia Court of Appeals has backed the dismissal of a lawsuit by Publix Supermarkets claiming a metro Atlanta county unconstitutionally hired outside counsel to pursue opioid litigation against the grocery chain, ruling Publix had "done nothing to assuage" the court's reasons for throwing out an almost identical suit earlier this year. 
- 
									October 14, 2025
									Catching Up With Delaware's Chancery CourtLast week at the Delaware Chancery Court, Vice Chancellor Lori W. Will ruled that Carlos Vasallo remains the CEO of Caribevision TV Network LLC, finding that majority investors' attempt to remove him under a defective 2019 agreement was invalid for lack of proper notice. 
- 
									October 14, 2025
									Covington, Sidley Guide $700M BioCryst Allergic Disease DealBioCryst Pharmaceuticals Inc. will purchase Astria Therapeutics Inc., a biopharmaceutical company focused on therapies for allergic and immunologic diseases, in a cash and stock deal worth about $700 million, the companies announced Tuesday. 
- 
									October 14, 2025
									High Court Won't Hear FDA Stem Cell Regulation FightThe U.S. Supreme Court on Tuesday declined to review a circuit court holding that a stem cell treatment derived from a patient's own tissue is subject to Food, Drug and Cosmetic Act regulations. 
- 
									October 10, 2025
									Ex-Temple Worker Can Sue Under ADA, Not As WhistleblowerA New Jersey federal judge ruled Friday that a longtime Fox Chase Cancer Center employee who claims she was ousted by a new supervisor after taking sick leave can add an Americans with Disabilities Act claim to her lawsuit, but not New Jersey or Pennsylvania whistleblower claims. 
- 
									October 10, 2025
									Federal Worker Unions Press For Immediate Block Of LayoffsUnions representing federal workers urged a California federal court Friday to immediately block the Trump administration from laying off workers amid the government shutdown as the administration acknowledged it had begun issuing reduction-in-force notices to thousands of employees. 
- 
									October 10, 2025
									DOJ Can't Pause Review Of UnitedHealth Deal Amid ShutdownA Maryland federal judge rejected the U.S. Department of Justice's bid to stay its recently settled case with UnitedHealth over the company's merger with Amedisys because of the government shutdown and lapse in appropriations, ruling that a stay would impede the DOJ's ability to evaluate the public interest in the settlement. 
- 
									October 10, 2025
									AstraZeneca Strikes 'Most Favored Nation' Price DealPharmaceutical giant AstraZeneca on Friday cut a deal with the Trump administration to reduce drug prices in the United States, agreeing to provide its medications for Medicaid beneficiaries at discount prices. 
- 
									October 10, 2025
									'LinkedIn For Doctors' Accused In Chancery Of Inflating DataA shareholder of a San Francisco-based networking company for healthcare workers filed a derivative suit Friday in the Delaware Chancery Court accusing the CEO and directors of overstating user engagement and deceiving investors. 
- 
									October 10, 2025
									Infosys' Counterclaims Against Competitor Tossed For NowA Texas federal court dismissed counterclaims from Infosys Ltd. accusing Cognizant TriZetto Software Group Inc. of monopolizing a market for healthcare software and related services after finding the allegations ignored potential competition from alternatives. 
- 
									October 10, 2025
									Experts Doubt Gold Card Will Siphon Off EB-5 InvestorsConcerns that President Donald Trump's gold card will siphon off noncitizens who would otherwise seek permanent residency through the EB-5 investor program might be overblown, with experts suggesting the program's 35-year track record and stability will continue attracting foreign investors. 
- 
									October 10, 2025
									Colorado Business Owner Gets Prison For $1.5M Tax FraudThe owner of a Colorado healthcare company who pled guilty to keeping over $1.5 million of her employees' withheld taxes received a one-year prison sentence on Friday. 
Expert Analysis
- 
								Series Law School's Missed Lessons: How To Make A Deal  Preparing lawyers for the nuances of a transactional practice is not a strong suit for most law schools, but, in practice, there are six principles that can help young M&A lawyers become seasoned, trusted deal advisers, says Chuck Morton at Venable. 
- 
								
								4th Circ. Clarifies Employer Duties For ADA Accommodations  The Fourth Circuit's recent decision in Tarquinio v. Johns Hopkins indicates that an employer's obligation to provide accommodations under the Americans with Disabilities Act may never arise if an employee obstructs the process, underscoring that ADA protections depend on cooperation between both parties, say attorneys at Hunton. 
- 
								
								From Clerkship To Law Firm: 5 Transition Tips For AssociatesExcerpt from Practical Guidance  Transitioning from a judicial clerkship to an associate position at a law firm may seem daunting, but by using knowledge gained while clerking, being mindful of key differences and taking advantage of professional development opportunities, these attorneys can flourish in private practice, say attorneys at Lowenstein Sandler. 
- 
								Opinion Fla. Misses Opportunity To Rectify Wrongful Death Damages  Florida Gov. Ron DeSantis' recent veto of a bill that would have removed certain arbitrary and unfair prohibitions on noneconomic wrongful death damages in medical negligence cases highlights the urgent need for reforms to current state law, say attorneys at Farah & Farah. 
- 
								
								Budget Act Should Boost Focus On Trade Compliance  Passage of the One Big Beautiful Budget Act, coupled with recent U.S. Department of Justice statements that it will use the False Claims Act aggressively to pursue trade, tariff and customs fraud, marks a sharp increase in trade-related enforcement risk, say attorneys at Debevoise. 
- 
								
								Associates Can Earn Credibility By Investing In Relationships  As the class of 2025 prepares to join law firms this fall, new associates must adapt to office dynamics and establish credible reputations — which require quiet, consistent relationship-building skills as much as legal acumen, says Kyle Forges at Bast Amron. 
- 
								
								New Colo. Teen Privacy Rules Signal National Regulatory Shift  Recently released proposed rule amendments to the Colorado Privacy Act that would create some of the most robust protections for minors' online data in the U.S. reflect an ongoing trend of states taking steps to extend privacy protection for their residents, complicating the compliance burden for companies, say attorneys at Morgan Lewis. 
- 
								
								A Shifting Trend In FDA Form 483 Disclosure Obligations  A New York federal court's Checkpoint Therapeutics decision extends a recent streak of dismissals of securities class actions alleging that pharmaceutical companies failed to disclose U.S. Food and Drug Administration Form 483 inspection reports, providing critical guidance for companies during the FDA approval process, say attorneys at Alston & Bird. 
- 
								
								Lessons From 7th Circ.'s Deleted Chat Sanctions Ruling  The Seventh Circuit’s recent decision in Pable v. Chicago Transit Authority, affirming the dismissal of an ex-employee’s retaliation claims, highlights the importance of properly handling the preservation of ephemeral messages and clarifies key sanctions issues, says Philip Favro at Favro Law. 
- 
								
								Mitigating Employer Liability Risk Under Sex Assault Rule  The American Law Institute's newly approved rule expands vicarious liability to employers for certain sexual assaults that employees commit, which could materially increase employers' exposure unless they strengthen safeguards around high-risk roles, say attorneys at Morgan Lewis. 
- 
								
								Breaking Down The Proposed Hemp Bill  A proposed bill in the U.S. House of Representatives, recently approved by the House Appropriations Committee, contains a rider that would significantly change the definition of hemp and dramatically reshape the current hemp-derived product market, say attorneys at King & Spalding. 
- 
								Series Quilting Makes Me A Better Lawyer  Turning intricate patterns of fabric and thread into quilts has taught me that craftsmanship, creative problem-solving and dedication to incremental progress are essential to creating something lasting that will help another person — just like in law, says Veronica McMillan at Kramon & Graham. 
- 
								
								Lessons Learned 3 Years After First CCPA Enforcement Action  Three years after the first public enforcement action under the California Consumer Privacy Act, Attorney General Rob Bonta has pursued a steady stream of enforcement actions across industries, providing a clearer picture of how the law is being interpreted and enforced, says Tatum Andres at Kilpatrick. 
- 
								
								How To Prep For Potential Passage Of SAFER Banking Act  The Secure and Fair Enforcement Regulation, or SAFER, Banking Act, could fundamentally reshape how financial institutions interact with cannabis businesses, so operators that move now to get their house in order will be best positioned to capitalize if and when change comes, says Alex Leonowicz at Howard & Howard. 
- 
								
								The Future Of Lab-Test Regs After FDA Rescinds Rule  The U.S. Food and Drug Administration recently rescinded its laboratory-developed tests rule in response to a Texas federal court decision this spring, reinforcing a separation of authority between the FDA and the Centers for Medicare & Medicaid Services, and calling into question the FDA's role in overseeing such tests without congressional action, say attorneys at Venable.